EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers

Daniella Vellone, Rebeca Leon, Zahra Goodarzi iD, Nils D Forkert iD, Eric E Smith, Zahinoor Ismail iD

Brain · 04.12.2025 · 148 (12) · 4345-4358

DOI: 10.1093/brain/awaf194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 02.06.2025. Verfasst von Daniella Vellone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Graduate Studies, University of Calgary, Calgary, Alberta T2N 1N4, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins, Apathy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Disease Neuroimaging Initiative, Northern California Institute for Research and Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apathy is a common neuropsychiatric symptom (NPS) in Alzheimer's disease (AD) but can emerge earlier in prodromal and even preclinical stages as part of mild behavioural impairment (MBI-apathy), a syndrome defined by emergent and persistent NPS. In dementia, apathy is associated with higher morbidity, mortality and caregiver distress. However, the significance of MBI-apathy in dementia-free persons, including its associations with AD biomarkers, remains unclear. This study aimed to determine whether MBI-apathy is associated with biomarker evidence of amyloid-beta (Aβ) and tau [phosphorylated (p-tau) and total (t-tau)] in CSF. Because MBI predicts incident dementia better than NPS without MBI, we aimed to determine the association between apathy and AD biomarkers when it occurred as part of the MBI syndrome and when it did not. Dementia-free participants with mild cognitive impairment or normal cognition from the Alzheimer's Disease Neuroimaging Initiative were stratified by NPS status (MBI-apathy, non-apathy MBI, non-MBI NPS and no-NPS) based on the Neuropsychiatric Inventory (NPI) or NPI-Questionnaire (NPI-Q). Linear regressions modelled cross-sectional associations between NPS status (predictor) and CSF biomarker ratios (Aβ42/Aβ40, p-tau181/Aβ42 and t-tau/Aβ42; primary outcomes) and levels (Aβ40, Aβ42, p-tau181 and t-tau; exploratory outcomes), adjusting for age, sex, apolipoprotein E4, education, Mini-Mental State Examination and NPI version. Hierarchical linear mixed-effects (LME) models assessed longitudinal associations over 2 years, incorporating random intercepts and slopes to account for repeated measures. Fixed effects included NPS status, all covariates from the linear regression model, and an interaction term between NPS status and time. Among 477 participants (176 cognitively normal), 52 had MBI-apathy. Primary cross-sectional analyses showed that, compared with the no-NPS group, MBI-apathy was associated with higher CSF p-tau181/Aβ42 [11.25% (2.56%–20.68%); adjusted P = 0.018] and t-tau181/Aβ42 [10.26% (2.42%–18.70%); adjusted P = 0.018]. Exploratory analyses revealed that MBI-apathy was associated with higher CSF p-tau181 [5.98% (0.50%–11.77%); P = 0.032]. Primary LME models showed that MBI-apathy was associated with higher CSF p-tau181/Aβ42 [11.34% (2.55%–20.88%); adjusted P = 0.022] and t-tau181/Aβ42 [10.34% (2.41–18.88%); adjusted P = 0.022] over 2 years. Exploratory LME models revealed that MBI-apathy was associated with higher CSF p-tau181 [6.03% (0.56%–11.81%); P = 0.032] and t-tau [4.96% (0.07%–10.09%); P = 0.049] over 2 years. MBI-apathy was significantly associated with core AD biomarkers cross-sectionally and longitudinally, over 2 years, underscoring its relevance as a marker of AD pathological burden. An overall MBI composite score might reflect a broader spectrum of pathology and warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-Peptidestau ProteinsApathyCognitive DysfunctionHumansMaleFemaleBiomarkersAgedAged, 80 and overPeptide FragmentsMiddle Aged

Stichwörter der Autor:innen

Amyloid Tau Neurodegeneration (ATN)Core biomarkersMotivational deficitsPreclinical Alzheimer's diseaseProdromal Alzheimer's disease

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsPeptide Fragments

Autor:innen und Institutionen

  • Faculty of Graduate Studies, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
  • Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
  • Mathison Centre for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada.
  • Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
  • Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
  • O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada.

ORCID-Profile: Zahra Goodarzi, Nils D Forkert, Zahinoor Ismail

Förderung

  • NIA NIH HHS
  • Alzheimer's Disease Neuroimaging Initiative
  • Northern California Institute for Research and Education
  • University of Southern California
  • NIBIB NIH HHS
  • Canadian Institutes for Health Research
  • Alzheimer’s Disease Neuroimaging Initiative
  • National Institute on Aging

Zitieren

APA

Vellone, D., Leon, R., Goodarzi, Z., Forkert, N. D., Smith, E. E., & Ismail, Z. (2025). Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers. Brain, 148(12), 4345-4358. https://doi.org/10.1093/brain/awaf194

Vancouver

Vellone D, Leon R, Goodarzi Z, Forkert ND, Smith EE, Ismail Z. Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers. Brain. 2025;148(12):4345-4358. doi:10.1093/brain/awaf194

BibTeX
@article{Vellone2025,
  author = {Vellone, Daniella and Leon, Rebeca and Goodarzi, Zahra and Forkert, Nils D and Smith, Eric E and Ismail, Zahinoor},
  title = {Mild behavioural impairment-apathy and core Alzheimer's disease cerebrospinal fluid biomarkers},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {12},
  pages = {4345--4358},
  doi = {10.1093/brain/awaf194}
}
Kostenlos starten →